Anti–Viral Activity for Novel Carbohydrate Binding Modules (mCBMs)
Pneumagen Ltd Announces Positive Anti–Viral Activity for Novel Glycan Approach in Preventing COVID–19 Infections
Novel Carbohydrate Binding Modules (mCBMs) block entry into airway cells for a range of viruses causing respiratory tract infections
Results show Pneumagen’s mCBMs demonstrate in vitro activity against coronaviruses